Orange S.A.
Orange S.A. (ORAN) Financial Performance & Income Statement Overview
Analyze Orange S.A. (ORAN) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Orange S.A. (ORAN) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Orange S.A. ORAN financial performance.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $20.42B | $19.84B | $22.58B | $21.55B |
| Cost of Revenue | $12.18B | $12.11B | $13.47B | $13.97B |
| Gross Profit | $8.24B | $7.72B | $9.10B | $7.57B |
| Gross Profit Ratio | $0.40 | $0.39 | $0.40 | $0.35 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $458.00M | $352.00M | $509.00M | $386.00M |
| Operating Expenses | $5.15B | $5.69B | $6.14B | $5.35B |
| Total Costs & Expenses | $17.34B | $17.81B | $19.62B | $19.32B |
| Interest Income | $0.00 | $0.00 | $745.00M | $679.00M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $677.00M |
| Depreciation & Amortization | $3.33B | $3.35B | $4.55B | $4.41B |
| EBITDA | $6.90B | $6.06B | $7.27B | $6.64B |
| EBITDA Ratio | $0.34 | $0.00 | $0.32 | $0.27 |
| Operating Income | $3.08B | $2.03B | $3.49B | $2.19B |
| Operating Income Ratio | $0.15 | -$0.61 | $0.15 | $0.10 |
| Other Income/Expenses (Net) | -$537.00M | -$529.00M | -$614.00M | -$512.00M |
| Income Before Tax | $2.55B | $1.50B | $2.21B | $1.55B |
| Income Before Tax Ratio | $0.12 | $0.00 | $0.10 | $0.07 |
| Income Tax Expense | $735.00M | $620.00M | $410.00M | $461.00M |
| Net Income | $1.53B | $824.00M | $1.39B | $877.00M |
| Net Income Ratio | $0.07 | $0.00 | $0.06 | $0.04 |
| EPS | $0.50 | $0.21 | $0.52 | $0.33 |
| Diluted EPS | $0.57 | $0.21 | $0.52 | $0.33 |
| Weighted Avg Shares Outstanding | $2.68B | $2.66B | $2.66B | $2.66B |
| Weighted Avg Shares Outstanding (Diluted) | $2.38B | $2.66B | $2.66B | $2.66B |
Over the past four quarters, Orange S.A. demonstrated steady revenue growth, increasing from $21.55B in Q2 2023 to $20.42B in Q4 2024. Operating income reached $3.08B in Q4 2024, maintaining a consistent 15% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $6.90B, reflecting operational efficiency. Net income rose to $1.53B, with EPS at $0.50. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan